@FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev
@MarkHFierce: EndoGastric pulled in another $13M in new venture finding for a device designed to help treat chronic acid reflux. Press release | Follow @MarkHFierce
@DamianFierce: Lawmakers, device industry on the same page as FDA user fee clears House, moves toward adoption. Article | Follow @DamianFierce
> A U.S. District Court judge threw out a 2010 lawsuit that accused Medtronic ($MDT) of violating W.L. Gore-held patents regarding the manufacturing of stent grafts. Story
> Covidien ($COV) is launching the Nellcor SpO2 respiratory monitor, designed to work with Philips Healthcare's IntelliVue patient monitoring platform. News
> Kansas company Post-T-Vac may have run up as much as $4.2 million in potentially bogus Medicare claims for the company's penis pumps, the Department of Health and Human Services inspector general alleges. Story
> Bio-Light Israeli Life Sciences Investments will acquire an ocular implant from a U.S. company that enables the sustained release of drugs to treat glaucoma. Story
> ReShape Medical has appointed former Allergan and Bausch + Lomb executive Robert E. Grant to its board of directors. The company is developing a non-surgical weight loss device. Release
Biotech News
@FierceBiotech: See the faces of biotech leaders at BIO2012 in our convention slideshow. Slideshow | Follow @FierceBiotech
@JohnCFierce: Interesting to note that if the ACA is tossed out by the Supremes, there goes 12 years of exclusivity for biologics and biosimilars pathway. Poof. | Follow @JohnCFierce
@RyanMFierce: My take from BIO 2012 on how the pharma herd faces hurdles with pricey new drugs. Report | Follow @RyanMFierce
> Pozen shares slide after FDA questions study for aspirin combo. More
> House rushes through approval of new PDUFA legislation. News
> Onyx clears big hurdle in high-stakes gamble on early carfilzomib approval. Article
> FDA panel turns thumbs down on Sanofi's anti-clotting drug. Story
Pharma News
@FiercePharma: AstraZeneca's Brilinta = lower healthcare costs, even at brand prices, finds cost-based analysis of PLATO data. More | Follow @FiercePharma
> Celgene's hopes for Revlimid stymied by regulatory setback. Story
> J&J close to $1.5B-plus Risperdal settlement, but not there yet. Article
> Is Madagascar 3's friendly lion a dangerous drug spokesman? More
> Anti-overtime ruling a disguised blessing for reps, recruiters say. Report
Pharma Manufacturing News
> Shasun cutting costs with Indian intermediates plant. Article
> Bard, Sartorius invest nearly $70M in Puerto Rico plants. Story
> CSL confirms convulsions appear tied to Fluvax manufacturing. More
Vaccines News
> HPV DNA vax should enter the clinic in 2013. More
> Therapeutic cancer vaccines: Optimism for the future at BIO2012. Article
> Anthrax vax to move into new Phase II trials. Story
> Genocea's HSV-2 vax to hit the clinic. News
CRO News
@NesaNFierce: Not shocked that the Philippines and Indonesia are eyed as emerging leaders in outsourcing. Population means a lot. More | Follow @NesaNFierce
> Can Russia emerge as a global biotech and manufacturing leader? More
> Filling services help Dalton seal manufacturing deal with Clarity. Article
> Biopharma looks at pros and cons of CMOs when debating in-house versus outsourcing. News
And Finally... Aneuclose, a Minnesota device startup, is developing a mesh device (combined with microsponges) for use as a treatment of narrow-neck aneurysms. Story